225 related articles for article (PubMed ID: 7041596)
1. Active and inactive renin after a single dose of captopril in hypertensive patients.
Glorioso N; Dessi Fulgheri P; Madeddu P; Fois G; Palermo M; Cocco F; Dettori S; Rappelli A
Am J Cardiol; 1982 Apr; 49(6):1552-4. PubMed ID: 7041596
[TBL] [Abstract][Full Text] [Related]
2. Hemodynamic effects of captopril in essential hypertension, renovascular hypertension and cardiac failure: correlations with short- and long-term effects on plasma renin.
Wenting GJ; de Bruyn JH; Man in't Veld AJ; Woittiez AJ; Derkx FH; Schalekamp MA
Am J Cardiol; 1982 Apr; 49(6):1453-9. PubMed ID: 6803562
[No Abstract] [Full Text] [Related]
3. Antihypertensive effects of captopril and saralasin in essential and renal hypertension.
Konrads A; Meurer KA; Hummerich W; Wambach G; Kindler J; Feltkamp H; Helber A
Am J Cardiol; 1982 Apr; 49(6):1558-60. PubMed ID: 7041597
[TBL] [Abstract][Full Text] [Related]
4. Increase in plasma aldosterone during prolonged captopril treatment.
Lijnen P; Staessen J; Fagard R; Amery A
Am J Cardiol; 1982 Apr; 49(6):1561-3. PubMed ID: 7041598
[TBL] [Abstract][Full Text] [Related]
5. Participation of the renin system in treatment-resistant hypertension as measured by acute blockade of the angiotensin converting enzyme.
Weber MA; Drayer JI; Priest RT; Chen TC
Am J Nephrol; 1982; 2(1):6-11. PubMed ID: 6295161
[TBL] [Abstract][Full Text] [Related]
6. [Conversion of inactive renin to active renin following acute angiotensin converting enzyme inhibition in essential hypertension and renovascular hypertension].
Kutkuhn B; Chlebowski H; Hollenbeck M; Grabensee B
Z Kardiol; 1989 Mar; 78(3):204-10. PubMed ID: 2652907
[TBL] [Abstract][Full Text] [Related]
7. Comparison of the hormonal and renal effects of captopril in severe essential and renovascular hypertension.
Aldigier JC; Plouin PF; Guyene TT; Thibonnier M; Corvol P; Menard J
Am J Cardiol; 1982 Apr; 49(6):1447-52. PubMed ID: 7041584
[No Abstract] [Full Text] [Related]
8. Captopril in the management of hypertension with renal artery stenosis: its long-term effect as a predictor of surgical outcome.
Atkinson AB; Brown JJ; Cumming AM; Fraser R; Lever AF; Leckie BJ; Morton JJ; Robertson JI; Davies DL
Am J Cardiol; 1982 Apr; 49(6):1460-6. PubMed ID: 7041585
[TBL] [Abstract][Full Text] [Related]
9. Long-term efficacy of captopril in renovascular and essential hypertension.
Case DB; Atlas SA; Marion RM; Laragh JH
Am J Cardiol; 1982 Apr; 49(6):1440-6. PubMed ID: 6803561
[TBL] [Abstract][Full Text] [Related]
10. Exaggerated response of renin secretion to captopril (SQ 14225) in renovascular hypertension.
Imai Y; Abe K; Otsuka Y; Sakurai Y; Ito T; Sato M; Haruyama T; Omata K; Hiwatari M; Yoshinaga K
Jpn Heart J; 1980 Nov; 21(6):793-802. PubMed ID: 7007685
[TBL] [Abstract][Full Text] [Related]
11. Effect of 12-hour infusions of saralasin or captopril on blood pressure in hypertensive conscious rats. Relationship to plasma renin, duration of hypertension, and effect of unclipping.
Bing RF; Russell GI; Swales JD; Thurston H
J Lab Clin Med; 1981 Aug; 98(2):302-10. PubMed ID: 7019368
[TBL] [Abstract][Full Text] [Related]
12. Acute and chronic effects of the angiotensin-converting enzyme inhibitor captopril in severe hypertension.
Havelka J; Vetter H; Studer A; Greminger P; Lüscher T; Wollnik S; Siegenthaler W; Vetter W
Am J Cardiol; 1982 Apr; 49(6):1467-74. PubMed ID: 6280477
[No Abstract] [Full Text] [Related]
13. [Inhibition of the angiotensin I converting enzyme with SQ-14225 (captopril) in the medical treatment of severe renovascular hypertension].
Martínez Amenós A; Caralps A; Rama H; Sarrias X; Alsina J
Rev Clin Esp; 1981 Sep; 162(6):265-8. PubMed ID: 7036249
[No Abstract] [Full Text] [Related]
14. Renal artery stenosis with normal angiotensin II values. Relationship between angiotensin II and body sodium and potassium on correction of hypertension by captopril and subsequent surgery.
Atkinson AB; Brown JJ; Davies DL; Leckie B; Lever AF; Morton JJ; Robertson JI
Hypertension; 1981; 3(1):53-8. PubMed ID: 7009427
[TBL] [Abstract][Full Text] [Related]
15. Captopril in clinical hypertension. Changes in components of renin-angiotensin system and in body composition in relation to fall in blood pressure with a note on measurement of angiotensin II during converting enzyme inhibition.
Atkinson AB; Morton JJ; Brown JJ; Davies DL; Fraser R; Kelly P; Leckie B; Lever AF; Robertson JI
Br Heart J; 1980 Sep; 44(3):290-6. PubMed ID: 7000102
[TBL] [Abstract][Full Text] [Related]
16. Acute changes in blood pressure and vasoactive hormones after captopril in hypertensive patients.
McGrath BP; Matthews PG; Johnston CI
Clin Exp Pharmacol Physiol; 1980; 7(5):487-91. PubMed ID: 7004680
[TBL] [Abstract][Full Text] [Related]
17. Active and inactive renin after captopril (SQ 14225) administration in hypertensive patients.
Goto T; Abe K; Otsuka Y; Seino M; Ito T; Imai Y; Haruyama T; Sato M; Hiwatari M; Sato K; Omata K; Kasai Y; Tajima J; Yoshinaga K
Tohoku J Exp Med; 1983 Jan; 139(1):103-11. PubMed ID: 6340244
[TBL] [Abstract][Full Text] [Related]
18. Captopril affects blood pressure equally in renovascular and essential hypertension and in the fluid-depleted anephric state.
de Bruyn JH; Wenting GJ; Man in 'T Veld AJ; Derkx FH; Schalekamp MA
Clin Sci (Lond); 1980 Dec; 59 Suppl 6():83s-86s. PubMed ID: 7004742
[TBL] [Abstract][Full Text] [Related]
19. A discrepancy between the effects of a single oral dose of captopril on blood pressure, plasma renin activity, and serum angiotensin-converting enzyme levels.
Lechi A; Covi G; Capuzzo MG; Lechi C; Minuz P; Delva P; Scuro LA
Int J Clin Pharmacol Ther Toxicol; 1983 Nov; 21(11):569-74. PubMed ID: 6317579
[TBL] [Abstract][Full Text] [Related]
20. Captopril in treatment-resistant essential and renal hypertension.
Aurell M; Delin K; Herlitz H
Scand J Urol Nephrol; 1982; 16(3):243-9. PubMed ID: 6761860
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
